Element Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,964
Closed -$8.69M 78
2023
Q3
$8.69M Sell
19,964
-11,888
-37% -$5.39M 0.77% 31
2023
Q2
$14.2M Buy
31,852
+1,634
+5% +$754K 0.96% 25
2023
Q1
$13.9M Buy
+30,218
New +$14.4M 1.05% 29
2019
Q3
Sell
-13,498
Closed -$3.81M 266
2019
Q2
$3.81M Sell
13,498
-9,120
-40% -$2.49M 0.26% 82
2019
Q1
$6.49M Buy
22,618
+1,605
+8% +$464K 0.2% 88
2018
Q4
$5.52M Buy
+21,013
New +$5.78M 0.16% 107
2018
Q3
Sell
-6,775
Closed -$1.61M 924
2018
Q2
$1.61M Buy
6,775
+3,770
+125% +$873K 0.04% 195
2018
Q1
$660K Sell
3,005
-190,986
-98% -$44.9M 0.02% 267
2017
Q4
$43.6M Buy
+193,991
New +$41.3M 0.9% 32
2015
Q3
Sell
-5,600
Closed -$919K 165
2015
Q2
$919K Buy
+5,600
New +$895K 0.33% 35

Other funds holding ELV

Element Capital Management's ELV Position: Q4 2023 in Review

Element Capital Management sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 19,964 shares — an estimated $8.69M sold.

Element Capital Management first reported a position in ELV in Q2 2015 and held it in 10 quarters. The position peaked at $43.6M in Q4 2017. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Element Capital Management reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Element Capital Management sold 19,964 Elevance Health shares in Q4 2023, an estimated $8.69M.
  • Element Capital Management first reported a position in Elevance Health in Q2 2015 and held it in 10 quarters.
  • Element Capital Management's Elevance Health position peaked at $43.6M in Q4 2017.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.